The MedicX Fund Limited Block listing application (8070N)

TIDMMXF

RNS Number : 8070N

The MedicX Fund Limited

11 August 2017

For immediate release

11 August 2017

MedicX Fund Limited

("MedicX Fund", "the Fund" or "the Company")

Block listing application

MedicX Fund Limited (LSE: MXF), the specialist primary care infrastructure investor in modern purpose-built primary healthcare properties in the United Kingdom and Republic of Ireland, has made an application to the UK Listing Authority for a block listing, for general business purposes, of 14,771,668 ordinary shares of no par value to be admitted to The Official List of the UK Listing Authority and to trading on The London Stock Exchange's main market for listed securities.

Shares issued under the block listing will be used to satisfy continuing market demand and the proceeds of share issuance under the block listing will be used for investment in accordance with the Company's investment policy.

The block listing is expected to become effective at 8.00 a.m. on 14 August 2017.

- End -

For further information please contact:

   MedicX Fund                                                                  [phone] 

David Staples, Chairman

   Octopus Healthcare Group                                               [phone] 

Mike Adams, Chief Executive Officer

   Canaccord Genuity                                                          [phone] 

Andrew Zychowski/Helen Goldsmith

   Buchanan                                                                      [phone] 

Charles Ryland/Vicky Hayns

Information on MedicX Fund Limited

MedicX Fund Limited ("MXF", "MedicX Fund", the "Fund" or the "Company", or together with its subsidiaries, the "Group") is the specialist primary care infrastructure investor in modern, purpose-built primary healthcare properties in the United Kingdom and Ireland, listed on the London Stock Exchange, with a portfolio comprising 157 properties.

The Investment Adviser to the Company is Octopus Healthcare Adviser Ltd, which is part of the Octopus Healthcare group. Octopus Healthcare invests in and develops properties as well as creating partnerships to deliver innovative healthcare buildings to improve the health, wealth and wellbeing of the UK. It currently manages over GBP1 billion of healthcare investments across a number of platforms, with a focus on five core areas: GP surgeries, care homes, special education schools, retirement housing and private hospitals. Octopus Healthcare is part of the Octopus group, a fast-growing UK fund management business with leading positions in several specialist sectors including healthcare property, energy, property finance and smaller company investing. Octopus manages GBP6 billion of funds for more than 50,000 retail and institutional investors.

Octopus Healthcare Adviser Ltd is authorised and regulated by the Financial Conduct Authority.

The Company's website address is www.medicxfund.com. Neither the contents of the Company's website nor the contents of any website accessible from hyperlinks on the Company's website (or any other website), nor the contents of any website accessible from hyperlinks within this announcement, are incorporated into, or forms part of, this announcement.

The Company's Legal Entity Identifier is 2138008POF35FTNFCB25.

This information is provided by RNS

The company news service from the London Stock Exchange

END

ALSLLFSLTIILLID

(END) Dow Jones Newswires

August 11, 2017 07:42 ET (11:42 GMT)